Among them, PSMA-targeted positron emission tomography (PET), especially 68Ga-PSMA-11, has been widely used for the detection, staging, posttreatment efficacy evaluation, and recurrence assessment of prostate cancer [11–13]. The gene discussed is FOLH1; the disease is prostate carcinoma.